Although not statistically significant, the high levels of IL-17 in group II indicate the role of IL-17 in the pathogenesis of psoriasis and the critical role of anti-inflammatory therapy in reducing IL-17 levels observed in groups three to seven. This evidence concerns the gene IL17A and psoriasis.